Richard Withagen News
-
Royal Ahold NV, the Dutch owner of the Stop & Shop supermarket chain, quadrupled a share buyback to 2 billion euros ($2.6 billion) to redistribute excess cash following the sale of a stake in Swedish retailer ICA.
-
D.E Master Blenders 1753 NV, the coffee and tea company spun off by Sara Lee Corp., said it’s in talks to be acquired by a group led by Joh. A. Benckiser in a bid that values the company at 7.6 billion euros ($9.7 billion).
-
In a dozen years running Reckitt Benckiser Group Plc, Bart Becht earned a reputation for developing innovative products and pushing them into far-flung regions. Achieving similar success at investment firm Joh. A. Benckiser, where he’s trying to assemble an $11 billion portfolio of second-tier coffee brands, will be a lot tougher.
-
Royal Ahold NV, the Dutch owner of the Stop & Shop chain, reported stronger U.S. sales than some analysts anticipated as American shoppers stocked up with provisions ahead of superstorm Sandy in October.
-
CSM NV agreed to sell its bakery supplies unit to Rhone Capital LLC for 1.05 billion euros ($1.36 billion) including debt, ending a 10-month search for a buyer as it seeks to focus on bio-based ingredients.
-
Royal Ahold NV , the Dutch owner of Stop & Shop supermarkets, said first-quarter profit rose 46 percent as higher earnings in the Netherlands offset sliding margins at its U.S. operations.
-
Unilever won European Union approval to buy Sara Lee Corp. ’s shower-gel and European detergents business after it agreed to dispose of the Sanex deodorant and body-wash brand in the region.
-
Unilever may this year post the fastest growth of Chief Executive Officer Paul Polman ’s tenure as the world’s second-largest consumer-products maker sells more in emerging markets and lifts prices on soaps and shampoos.
-
Heineken NV, the world’s third- biggest brewer, reported full-year earnings that beat estimates as cost savings offset weaker beer shipments in western Europe.
-
Advent International Corp. will offer to buy Dutch pharmacy chain Mediq NV for 775 million euros ($1 billion) in cash as it seeks to expand in the health-care distribution industry.
|
|
Most Popular on Bloomberg
|
| |